Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV.
King JM, Dobbins T, Keen P, Cornelisse VJ, Stoové M, Nigro SJ, Asselin J, Higgins N, Mao L, Aung HL, Petoumenos K, McGregor S
HIV + AIDS
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial.
McKetin R, Degan TJ, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly PJ, Turner A, Clare PJ, Dean OM, Arunogiri S, Colledge-Frisby S, Koeijers J, Goodman-Meza D, Sinclair B, Reid D, Hill H, Hayllar J, Christmass M, Cordaro F, Lundin R, Liaw W, Liu D, Holyoak E, Wu BT, Keygan J, Kontogiannis A, Palmer L, Morrison C, Wrobel A, Hyland B, Byrne M, Russell S, Zahra E, Berk M
Alcohol and Other Drugs
Healthcare-associated infections and antimicrobial use at a major referral hospital in Papua New Guinea: a point prevalence survey.
Curtis SJ, Barnabas R, Cairns KA, Cameron D, Coghlan B, Jones R, Joseph J, Kali A, Kep D, Klintworth G, Levy S, Mason M, Norrie M, Peel T, Tamolsaian G, Telenge J, Tumu N, Stewardson AJ, Ak G, COMBAT-AMR group
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1.
Dans MG, Boulet C, Watson GM, Nguyen W, Dziekan JM, Evelyn C, Reaksudsan K, Mehra S, Razook Z, Geoghegan ND, Mlodzianoski MJ, Goodman CD, Ling DB, Jonsdottir TK, Tong J, Famodimu MT, Kristan M, Pollard H, Stewart LB, Brandner-Garrod L, Sutherland CJ, Delves MJ, McFadden GI, Barry AE, Crabb BS, de Koning-Ward TF, Rogers KL, Cowman AF, Tham WH, Sleebs BE, Gilson PR
Malaria